Skip to main content

Duration of Follow Up for New Molecular Entities Approved in 2011

    Basic Details
    Date Posted
    Medical Product
    new molecular entities (NMEs)

    The purpose of this analysis was to describe the baseline characteristics and the duration of follow-up time among new users of 30 new molecular entities (NMEs) approved in 2011 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD). We distributed this request to 17 Data Partners on January 31, 2019. The study period included data from January 1, 2011 to June 30, 2018.